We leave the lab to find out what people know about cell and gene therapy.
Phil Gotwals talks about his vision for the future of business development for research.
Novartis announces fourth quarter and full year financial results for 2019 at 07:00 CET on January 29, 2020.
Novartis Pharmaceuticals Corporation researches, develops, manufactures & markets innovative prescription drug treatments for diseases and conditions.
This site is intended for US Residents Only